Top Markets
#1 Islamic Coin Islamic Coin +151.51%
#2 Akedo Akedo +55.89%
#3 DOVU DOVU +48.37%
#4 Velvet Velvet +44.60%
#5 Black Phoenix Black Phoenix +34.05%
#6 Cross Cross +27.56%
#7 Cap Cap +19.95%
#8 DoubleZero DoubleZero +17.42%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +9.92%
#10 Pieverse Pieverse +9.84%
Coin of the day
Islamic Coin Islamic Coin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
OKYO Pharma Limited OKYO Pharma Limited

OKYO Pharma Limited

OKYO
Kedudukan dalam Saham #39874
OKYO Pharma Limited, a biopharmaceutical entity operating at the preclinical... OKYO Pharma Limited, a biopharmaceutical entity operating at the preclinical stage, focuses on creating treatments for individuals experiencing inflammatory conditions of the eye and chronic ocular pain. Established in 2007 and headquartered in London, UK, the company's primary investigational drug is OK-101, aimed at addressing dry eye syndrome. Additionally, the firm is advancing OK-201, a preclinical analogue developed from bovine adrenal medulla, designed to alleviate neuropathic ocular pain.
Harga Saham
$0.01904982
Disegerakkan terakhir: 2023-05-19
Modal Pasaran
$316.00K
Perubahan (1 hari)
-17.05%
Perubahan (1 tahun)
0.00%
Negara
GB
Perdagangan OKYO Pharma Limited (OKYO)

Kategori

Healthcare
EPS untuk OKYO Pharma Limited (OKYO)
EPS setakat 2026 TTM: 0
Menurut laporan kewangan terkini dan harga saham OKYO Pharma Limited, EPS semasa syarikat (TTM) adalah 0. Pada akhir tahun 2026, syarikat mempunyai EPS sebanyak 0 sama dengan EPS tahun 2026 iaitu 0.
Sejarah EPS untuk OKYO Pharma Limited dari 2026 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
Tidak cukup data untuk tarikh yang disediakan.
EPS untuk syarikat atau pesaing yang serupa
Syarikat EPS Perbezaan EPS Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE